Stryker (NYSE: SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic ...

Stryker (NYSE: SYK) today announced plans to showcase the latest innovations across a handful of its orthopedic product lines.

I am downgrading Stryker Corporation to a Hold rating with a fair value of $380 per share, despite strong performance and growth prospects. Stryker's Mako spine and shoulder applications are set to ...

MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder ...

Think Surgical today announced the first completed cases using the TMINI miniature robotic system with the Stryker Triathlon knee system.

Analysts balked at the price Stryker paid for Mako back in 2013 – $1.65 billion – but the company has proven time and again that the juice was worth the squeeze. Even with the unpredictability of the ...

Stryker Corporation SYK recently unveiled the next generation of its Mako SmartRobotics system at the American Academy of Orthopaedic Surgeons’ 2025 Annual Meeting, reinforcing its commitment to ...

Stryker has started a limited market release of its Mako RPS handheld robotic system for total knee procedures, the company said Monday. Mako RPS, short for robotic power system, is aimed at surgeons ...

PORTAGE, Mich., Feb. 9, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the limited market release of Mako RPS (Robotic Power System) for Total Knee, an ...

In a report published Wednesday morning, Stryker SYK, a leading medical technology company, announced they have come to an agreement to acquire MAKO Surgical MAKO for $1.65 billion. Stryker will ...